10/21/2025 08:00
NTT DATA Strengthens Global Insurance Leadership with Acquisition of Alchemy Technology Services

NTT DATA, a global leader in AI, digital business and technology services, today announced the acquisition of Alchemy Technology Services, a specialist insurance technology consultancy. The move reinforces NTT DATA’s commitment to transforming the global insurance ecosystem, addressing current and emerging challenges around agility, modernization and scalability. In addition to its strong consultancy and Guidewire credentials, Alchemy brings deep expertise in the specialty insurance market, par...

10/21/2025 08:51
Polpharma Biologics announces commercial launch of Europe’s first Pre-filled Syringe presentation of a ranibizumab biosimilar

Polpharma Biologics today announced Ranivisio® PFS (ranibizumab biosimilar pre-filled syringe), is now commercially available in France. Ranivisio® is the first Lucentis® biosimilar which is offered in a convenient pre-filled syringe (PFS) presentation in Europe, setting a new standard for affordable biologics in ophthalmic care. This innovative configuration provides precise dosing and ease of use, supporting efficient administration for patients with neovascular (wet) age-related macular de...

10/21/2025 09:12
Ferrer Completes Recruitment of 220 Patients for the PROSPER Study, a Phase II Clinical Trial in Progressive Supranuclear Palsy (PSP), Two Months Ahead of Schedule

Spanish international pharmaceutical company Ferrer has announced the completion of patient recruitment for the PROSPER study, a Phase II clinical trial designed to assess the efficacy, safety, and pharmacokinetics of FNP-223, an orally available, potent and selective inhibitor of the OGA enzyme, in-licensed from Asceneuron, aimed at slowing disease progression in Progressive Supranuclear Palsy (PSP)1. This press release features multimedia. View the full release here: https://www.businesswire...

10/21/2025 10:00
IFF and BASF Announce Strategic Collaboration to Drive Next-Generation Enzyme and Polymer Innovation

IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients, health and biosciences — announced a strategic collaboration with BASF, one of the world’s largest chemical companies and leader in sustainable product innovation, to accelerate the development of IFF’s Designed Enzymatic Biomaterials™ technology platform and create next-generation enzyme technologies for fabric, dish and personal care as well as industrial cleaning applications. This press release features multimedia....

AFP statement on brief detention of journalist in Nigeria

On October 20, 2025, police in Nigeria briefly detained AFP video journalist John Okunyomih outside the Transcorp Hilton Hotel in the capital Abuja.

On October 20, 2025, police in Nigeria briefly detained AFP video journalist John Okunyomih outside the Transcorp Hilton Hotel in the capital Abuja.
10/21/2025 12:00
Aptiv Unveils Gen 8 Radars to Power the Future of ADAS

Aptiv PLC (NYSE: APTV), a global technology company focused on enabling a safer, greener, and more connected future, today announced its most advanced radar technology to date—engineered to meet the evolving demands of future advanced driver-assistance systems (ADAS). Powered by Aptiv’s proprietary antenna and silicon design, the Gen 8 radars deliver the class-leading performance and high-resolution sensing needed to support AI- and machine learning–driven ADAS capabilities. This press release...

10/21/2025 12:00
Carevance platform expands access to GE HealthCare’s clinical excellence with advanced patient monitoring and new perioperative hypotension management capability

GE HealthCare (Nasdaq: GEHC) today announced it has received CE mark for its Carevance™ patient monitor, advancing accessible and reliable care for more customers starting in Europe. Built on GE HealthCare’s clinical excellence, Carevance offers a clinically reliable and cost-effective solution with validated parameters and an intuitive, efficient workflow that can help empower care teams to stay focused on their patients. Hospitals today are facing new challenges, from staffing shortages and i...

10/21/2025 12:00
Enedym Inc. Secures Investment from Honda Motor Co., Ltd.

Enedym Inc. (“Enedym”), a technology company that develops next generation switched reluctance motors (SRMs), electric powertrains, and powertrain controls, announced today an investment from Honda Motor Co., Ltd. (“Honda”). Honda invests in innovative startups through its global open innovation program, Honda Xcelerator Ventures. The new investment will be used to accelerate Enedym’s patented motor technology development and ramp up its operations. Enedym is headquartered at the McMaster Inn...

10/21/2025 12:00
Wilmington PharmaTech Continues Expansion with Significant Investment from Curewell Capital

Wilmington PharmaTech (“WPT”), a U.S.-based specialty contract research, development, and manufacturing organization (CRDMO) focused on custom small molecule API development and manufacturing, today announced a majority investment by Curewell Capital (“Curewell”), a Los Angeles-based private equity firm focused on building industry-leading healthcare companies. Hui-Yin “Harry” Li, Ph.D., Founder and CEO of WPT, will retain a significant ownership stake and will continue to lead the business alo...

10/21/2025 12:00
Axelera Announces Europa AIPU, Setting New Industry Benchmark for AI Accelerator Performance, Power Efficiency and Affordability

Axelera AI, the leading provider of purpose-built AI hardware acceleration technology, today announced Europa™, an AI processor unit (AIPU) that sets a new performance/price standard for multi-user generative AI and computer vision applications. Europa’s combination of processing power, energy and thermal efficiency, compact packaging, and multiple form factor options make it ideal for compute-intensive, multi-modal AI inference applications from the edge to enterprise servers. Designed to be c...